Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition
February 04 2021 - 4:30PM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in
precision genetic medicine for rare diseases, today announced the
four winners of the Rare Lessons lesson planning competition.
Sarepta has granted the winning authors $2,500 each and $2,500 to
the educational institution with which each is affiliated. The
winning submissions are now available on sharemylesson.com, and
more information about the authors can be found at
Sarepta.com/rarelessons.
Rare Lessons competition winners and lesson plan
titles:
- Laura Doyle, Atlanta International
School, Atlanta, Ga.: Rare Diseases Lesson Plan
- Jessica Keogh, West Chester Area
School District, Exton, Penn.: Empathy
- Sarah Kesty, Castle Park Middle
School, Chula Vista, Calif.: The Mystery of Rare Diseases
- Kaitlin Payne, South Topsail
Elementary School, Hampstead, N.C.: Not Weird, Just Different
“Each of these lesson plans is unique, but share
in their creativity, passion and innovative thinking aimed at
building awareness of rare disease and promoting diversity and
inclusion within the classroom and community. Though judges were
blinded to author identity and background, another remarkable
commonality is the recipients’ connections to rare disease, in most
cases either living with a rare disease or caring for a loved one
with a rare disease,” said Diane Berry, Ph.D., Sarepta’s Senior
Vice President of Global Health Policy, Government and Patient
Affairs. “We encourage everyone to share the sharemylesson.com
links with educators in your lives, take action to start a
conversation and increase understanding of rare disease, and
ultimately help alleviate feelings of isolation often experienced
by children and families having to navigate living with a rare
disease. Sarepta congratulates all the winning authors and extends
our thanks and appreciation to all contest entrants and the
selection committee for generously giving of their time to review
the lesson plan submissions.”
This program is intended to promote the
development and implementation of educational materials to increase
rare disease awareness in the K-12 classroom setting. The
competition was open to educators in grades K-12, based in the
United States, and actively teaching in an accredited educational
institution. A blinded selection committee reviewed and selected
the submissions. For the Rare Lessons contest, Sarepta partnered
with sharemylesson.com, a platform that offers broad availability
of lesson plans for educators and schools across the country.
About Sarepta
TherapeuticsAt Sarepta, we are leading a revolution in
precision genetic medicine and every day is an opportunity to
change the lives of people living with rare disease. The Company
has built an impressive position in Duchenne muscular dystrophy
(DMD) and in gene therapies for limb-girdle muscular dystrophies
(LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth
(CMT), and other CNS-related disorders, with more than 40 programs
in various stages of development. The Company’s programs and
research focus span several therapeutic modalities, including RNA,
gene therapy and gene editing. For more information, please
visit www.sarepta.com or follow us
on Twitter, LinkedIn, Instagram and Facebook.
Internet Posting of
InformationWe routinely post information that may be
important to investors in the 'For Investors' section of our
website
at www.sarepta.com. We encourage investors and potential investors to
consult our website regularly for important information about
us.
Source: Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Investors:Ian Estepan, 617-274-4052,
iestepan@sarepta.com
Media:Tracy Sorrentino, 617-301-8566,
tsorrentino@sarepta.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024